#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinopathy of prematurity Noonan syndrome Nephropathy Squamous cell carcinoma of the cervix Diffuse large B-cell lymphoma recurrent Extra-osseous Ewing's sarcoma Nasopharyngeal cancer Pericarditis Deafness IgA nephropathy Neurodevelopmental disorder Chronic lymphocytic leukaemia recurrent Crohn's disease Glycogen storage disease type V Dedifferentiated liposarcoma More trials…

    Learn about Rare Diseases

    Hereditary ataxia – Treatment Glomerulonephritis membranoproliferative – Basic Information Shprintzen-Goldberg syndrome – Trials in Disease Brain stem glioma – Life with Disease Crigler-Najjar syndrome – Trials in Disease Andersen-Tawil syndrome Chronic granulomatous disease – Basic Information Synovial sarcoma recurrent – Basic Information Hairy cell leukaemia recurrent Familial amyotrophic lateral sclerosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ropivacaine BUDOPRUTUG GS-1720 Olanzapine HSP-CAR30 Tinzaparin Sodium Pantoprazole Alendronate Sodium Monohydrate SODIUM SULFIDE NONAHYDRATE Timolol Maleate Bosutinib Cimetidine ZAMPILIMAB Vortioxetine Hydrobromide ULTEVURSEN GS-248 Barzolvolimab 177Lu-Dpi-4452 Autologous Pancreatic Islets Abemaciclib More therapies…

    Learn about Your Condition

    Placenta praevia Chondrocalcinosis Atrial fibrillation Mast cell activation syndrome Complex regional pain syndrome Cognitive disorder Hip arthroplasty Bipolar disorder Carpal tunnel syndrome Combined immunodeficiency Pelvic venous thrombosis Hepatorenal syndrome Essential hypertension Red blood cell abnormality Metastatic malignant melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Preventing Bleeding in Children with Severe von Willebrand Disease Using Vonicog Alfa and Octocog Alfa

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Von Willebrand’s disease
    Investigated Drugs:
    • Octocog Alfa
    • Vonicog Alfa
    France Ireland Italy Spain

  • Study on the Safety and Effectiveness of HDP-101 for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Hdp-101
    Germany Hungary Poland Romania Spain

  • Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Ceritinib
    • Dabrafenib
    • Dactinomycin
    Norway

  • Study on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Letrozole
    Austria Germany

  • Study of Linvoseltamab in Adults with Relapsed or Refractory Multiple Myeloma

    Recruiting

    2 1 1
    Investigated Drugs:
    • Diphenhydramine Hydrochloride
    • Linvoseltamab
    • Dexamethasone
    Belgium Spain

  • Study on Sedation Effects of Dexmedetomidine vs. Midazolam in Mechanically Ventilated Preterm Infants

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Midazolam
    France
Previous Page
1 … 348 349 350 351 352 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!